SCHEMBL13814552

SCHEMBL13814552

CCCN(CC1CC1)S(=O)(=O)c1ccc(C(C)C)cc1

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
CNR2 P34972 4/20 0.46
HTR2A P28223 1/20 0.45
HTR2C P28335 1/20 0.45
CA12 O43570 7/20 0.44
CA9 Q16790 7/20 0.44
CA2 P00918 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
SLC22A6 Q4U2R8 1/20 0.44
SLC22A8 Q8TCC7 1/20 0.44
ABCC2 Q92887 1/20 0.44
SLC22A12 Q96S37 1/20 0.44
UGT1A7 Q9HAW7 1/20 0.44
SLC22A11 Q9NSA0 1/20 0.44
LMNA P02545 3/20 0.44
CA1 P00915 5/20 0.43
CNR1 P21554 2/20 0.43
TAS2R14 Q9NYV8 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21514992 0.88 ALDH1A1 (0.46) ALDH1A1CNR2HTR2AHTR2CCA12
SCHEMBL5018945 0.85 CA9 (0.58) ALDH1A1CNR2CA12CA9CA2
SCHEMBL10282782 0.84 TAS2R14 (0.57) ALDH1A1CNR2CA12CA9CA2
SCHEMBL12646345 0.83 TAS2R14 (0.50) ALDH1A1CNR2HTR2AHTR2CCA12
SCHEMBL16503464 0.83 ALDH1A1 (0.48) ALDH1A1CNR2HTR2AHTR2CCA12
SCHEMBL10258034 0.83 TAS2R14 (0.53) ALDH1A1CNR2CA12CA9CA2
SCHEMBL12169380 0.81 ALDH1A1 (0.47) ALDH1A1CNR2HTR2AHTR2CCA12
SCHEMBL5018778 0.75 LMNA (0.66) ALDH1A1CNR2RAB9ASMN1; SMN2LMNA
SCHEMBL3848953 0.75 CNR2 (0.62) CNR2LMNACNR1TAS2R14
SCHEMBL14132730 0.74 CNR2 (0.46) ALDH1A1CNR2HTR2AHTR2CCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130296364-A1 MODULATORS OF ATP-BINDING CASSETTE-TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-11-07 US disclosed
US-8324207-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-12-04 US disclosed
US-20090143381-A1 MODULATORS OF ATP-BINDING CASSETTE-TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED 2009-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130296364-A1 MODULATORS OF ATP-BINDING CASSETTE-TRANSPORTERS CFTR, ABCB1, ABCC2 ALDH1A1 1985/4885CNR2 1564/4885HTR2A 2930/4885
US-20090143381-A1 MODULATORS OF ATP-BINDING CASSETTE-TRANSPORTERS CFTR, ABCB1, ABCC2 ALDH1A1 1985/4885CNR2 1564/4885HTR2A 2930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.